Da
Daiichi Sankyo EU
Munich DEFounded 20052,000 employees
Private CappharmaPrivateOncology
Platform: DXd EU Ops
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| DAI-6285 | DAI-6285 | Phase 1/2 | 2 | BET | Pompe | ||
| Doxafotisoran | DAI-4568 | Phase 3 | 3 | LAG-3 | AS | ||
| DAI-7966 | DAI-7966 | Preclinical | 2 | CDK4/6 | MG | ||
| Pexavorutinib | DAI-8075 | Preclinical | 1 | GIP-R | MCL |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (10)